EFFORT: EFFicacy Of Adavosertib Plus Olaparib, PARP-resistant Ovarian Cancer
Adavosertib with or without olaparib shows efficacy in women with PARP inhibitor-resistant ovarian cancer (Abstract #5505) Clinical trial results from the randomized, non-comparative Phase II EFFORT study showed that...
Read More